Note: This document has been translated from the Japanese original for reference purposes only. In the event of any
discrepancy between this translated document and the Japanese original, the original shall prevail.

Summary of Financial Statements for the Three Months
Ended June 30, 2024 [IFRS] (Consolidated)
August 2, 2024
Company name:
JMDC Inc.
Listing:
Tokyo Stock Exchange
Stock code:
4483
URL:
https://www.jmdc.co.jp/en/
Representative:
Ryo Noguchi, President and CEO
Inquiries:
Tomohiro Mochizuki, Executive Officer and CFO
TEL:+81-3-5733-5010
Scheduled date to commence dividend payments:–
Preparation of supplementary material on financial results:
Yes
Holding of financial results presentation meeting:
None(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the first three months of the fiscal year ending
March 31, 2025 (from April 1, 2024 to June 30, 2024)(1) Consolidated operating results (cumulative)
RevenueThree months ended
June 30, 2024
June 30, 2023

Three months ended
June 30, 2024
June 30, 2023

(Percentages indicate year-on-year changes.)

Operating profit

Profit before tax

ProfitMillions of yen%

Millions of yen%

Millions of yen%

Millions of yen

%

8,422
6,698

25.7
16.0

1,089
2,546

(57.2)
135.5

1,072
2,552

(58.0)
127.8

730
2,040

(64.2)
168.5

Profit attributable toowners of parent

Total comprehensive
incomeBasic earnings
per share

Diluted earnings
per share

Millions of yen%

Millions of yen

%

Yen

Yen

727
2,040

(64.3)
166.5

731
2,043

(64.2)
167.8

11.14
32.42

11.03
31.07

Reference: EBITDA

Three months ended June 30, 2024
¥1,718 million [2.3%]
Three months ended June 30, 2023
¥1,679 million [10.4%]
Note: EBITDA: Operating profit + Depreciation and amortization ± Other income and/or expenses(2) Consolidated financial position
Total assets
As ofJune 30, 2024
March 31, 2024

Total equity

Equity attributable toowners of parent

Ratio of equity
attributable to ownersof parent%

Millions of yen

Millions of yen

Millions of yen

121,369
122,452

70,39770,68670,29670,59057.9
57.6

2. Cash dividends
Annual dividends
First quarter-end Second quarter-end Third quarter-end
Yen
Fiscal year ended
March 31, 2024
Fiscal year ending
March 31, 2025

Yen–

Fiscal year-end

Yen

Total

Yen

Yen

0.00

–

14.00

14.00

–

–

–

–

–

Fiscal year ending
March 31, 2025
(Forecast)

Note: Revisions to the forecast of cash dividends most recently announced: None

3. Consolidated earnings forecasts for the fiscal year ending March 31, 2025 (from
April 1, 2024 to March 31, 2025)
RevenueSix months ending
September 30, 2024
(cumulative)
Fiscal year ending
March 31, 2025

Operating profit Profit before tax

Millionsof yen%18,70036.02,800 (22.3)

2,750 (23.9)

43,000

32.8

9,300

9,100

Millionsof yen%32.7

Millionsof yen%31.7(Percentages indicate year-on-year changes.)
ProfitBasic
Profitattributable to earnings perowners of parent
shareMillionsof yen%Millionsof yen%Yen

1,850 (30.5)

1,850 (30.5)

28.31

6,200

6,200

94.90

34.0

34.6

Note: Revisions to the earnings forecasts most recently announced: Yes
For details, please refer to “1. Outline of business performance (3) Explanation of consolidated earnings forecasts andother forward-looking statements” on page 5 of the attached materials.
Reference: EBITDA
Six months ending September 30, 2024 (cumulative) ¥4,000 million [21.1%]
Fiscal year ending March 31, 2025
¥12,000 million [26.7%]

* Notes(1) Significant changes in the scope of consolidation during the period: None
(2) Changes in accounting policies and changes in accounting estimates(i) Changes in accounting policies required by IFRS:
None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates:
None(3) Number of issued shares (ordinary shares)(i) Total number of issued shares at end of the period (including treasury shares)
As of June 30, 2024

65,338,808 shares

As of March 31, 2024

65,331,208 shares(ii) Number of treasury shares at end of the period
As of June 30, 2024

731 shares

As of March 31, 2024

647 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning of the
fiscal year)
For the three months ended June 30, 2024

65,331,692 shares

For the three months ended June 30, 2023

62,939,621 shares* Review of the Japanese-language originals of the attached quarterly consolidated financial
statements by certified public accountants or an audit corporation: None
* Proper use of earnings forecasts, and other special items
Notes on forward-looking statements
The forward-looking statements, including earnings forecasts, contained in these materials are based on
information currently available to the Company and on certain assumptions deemed to be reasonable by
the Company. Actual business and other results may differ substantially due to various factors. For details
regarding matters related to earnings forecasts, please refer to page 5 of the attached materials.
How to obtain supplementary documents on financial results
Supplementary documents on financial results are released via TDnet on the same day.

JMDC Inc. (4483)

Attached Material Index
1. Outline of business performance .............................................................................................................. 2(1) Outline of business performance for the three months ended June 30, 2024 ..................................... 2(2) Outline of financial position for the three months ended June 30, 2024 ............................................ 4(3) Explanation of consolidated earnings forecasts and other forward-looking statements ..................... 5
2. Condensed quarterly consolidated financial statements and significant notes thereto ............................. 6(1) Condensed quarterly consolidated statement of financial position .................................................... 6(2) Condensed quarterly consolidated statement of profit or loss and condensed quarterly consolidated
statement of comprehensive income .................................................................................................. 7(3) Condensed quarterly consolidated statement of changes in equity .................................................... 9(4) Condensed quarterly consolidated statement of cash flows ............................................................. 11(5) Notes to condensed quarterly consolidated financial statements...................................................... 12
Notes on going concern assumption ................................................................................................. 12
Segment information ........................................................................................................................ 12
Significant subsequent events........................................................................................................... 13-1-

JMDC Inc. (4483)

1. Outline of business performance(1) Outline of business performance for the three months ended June 30, 2024
JMDC Inc. (the “Company”) is promoting the health of citizens, and delivering increased value of
medical service providers and helping optimize their operations through gathering diverse data on theJapanese healthcare industry and thus benefiting society, with the aim of realizing a sustainable
healthcare system by leveraging data and ICT.
In the Healthcare-Big Data segment, to promote the health services for payers, centered on healthinsurance unions, we provide analysis services for data held by payers as well as personal health record(PHR) services developed by the Company. We also provide services such as medical data analysis andmedical factoring to medical institutions as well as medicine databases. Furthermore, we have created a
database of anonymously processed information in the course of pursuing this business and arepromoting scientific and industrial applications of this data.
In the Tele-medicine segment, we provide a matching service that connects medical institutions lacking
a sufficient number of radiologists with contracted radiologists using a remote image interpretation
system, as well as an ASP service that connects medical institutions with radiologists via the cloud toenable remote diagnostic imaging.
In the Dispensing Pharmacy Support segment, we develop and sell systems such as receipt computersand electronic medication history systems to health insurance pharmacies.
Operating results for the three months ended June 30, 2024 are as follows.
(Operating results)(Millions of yen)
Category
Revenue

11th fiscal year
Three months ended
June 30, 2023

12th fiscal year
Three months ended
June 30, 2024

6,698

8,422

Operating profit

2,546

EBITDA [margin]

1,679

1,089
[25.1%]

1,718[20.4%]

YoY change
1,724

25.7%

(1,456)(57.2)%

38

2.3%(Segment results)(Millions of yen)
11th fiscal year
12th fiscal year
Category
Three months ended
Three months ended
YoY change
June 30, 2023
June 30, 2024
Segment revenue
4,497
6,606
2,108
46.9%
Healthcare-Big
Data
Segment profit [ratio]
1,294[28.8%]
1,301[19.7%]
6
0.5%
Segment revenue
1,307
1,500
193
14.8%
Tele-medicine
Segment profit [ratio]
448[34.3%]
532[35.5%]
84
18.8%
Segment revenue
969
326
(643)
(66.4)%
Dispensing
Pharmacy Support Segment profit [ratio]
87[9.1%]
58[18.0%](29)(33.2)%
Segment revenue
(76)
(10)
65
–
Adjustment
Segment profit
(151)
(174)
(23)
–
Revenue
6,698
8,422
1,724
25.7%
Total
EBITDA [margin]
1,679[25.1%]
1,718[20.4%]
38
2.3%(Note) EBITDA is an objective indicator for judging the achievement of the JMDC Group’s (the “Group’s”) management
policies and strategies or management objectives. The Group uses EBITDA to measure the performance of eachsegment and believes that it is a useful and necessary measure to assess the Group’s performance more effectively.
The formulas for calculating EBITDA and EBITDA margin are as follows.
 EBITDA:
Operating profit + Depreciation and amortization ± Other income and/or expenses
 EBITDA margin: EBITDA / Revenue x 100-2-

JMDC Inc. (4483)

Results by each segment are as follows.
Healthcare-Big Data
The Group possesses the largest scale of healthcare big data in Japan that is available for public throughdata anonymization of receipts (admitted patients, day patients, prescriptions), medical examinations andmember records received from health insurance unions. During the three months ended June 30, 2024,
the number of contracted health insurance unions and the annual transaction value per customer at
pharmaceutical and insurance companies, which use and utilize the healthcare big data, each continued
to increase on a year-on-year basis, and the business is continuing to expand.
Moreover, the Pep Up health information platform developed by the Company is used to generate
individualized advice and display risk of diseases for every individual user based on the above healthcare
big data. The number of IDs issued for Pep Up continued to expand during the three months ended June30, 2024.
In addition to the above-mentioned business expansion, the Company gathered companies andorganizations that will work to implement health management that exceeds industry organizations, andcommenced full-scale operations for the “Health & Productivity Management Alliance” in June 2023,
expanding to 409 companies and organizations as of June 30, 2024. The mission of this alliance is torevitalize Japanese companies through the health of employees and enable the sustainability of the healthinsurance system, and it is currently promoting three initiatives to hold study sessions and seminars,
create health management assessments based on surveys and data analysis, and build information
platforms for health management solutions. Going forward, the Company will accelerate the creation of
results and business, by further expanding the activities and implementing health management.
In January 2024, the Company made Cancerscan Inc. its subsidiary. The Company will further accelerate
the expansion of the Group’s business in the Payers/Individuals fields by developing services andsolutions that the Company has cultivated through transactions with health insurance unions throughCancerscan’s strong client base in local governments, and by providing solutions, such as lifestyle-relateddisease treatment programs developed by applying Cancerscan’s strength in behavioral modification
know-how, to the health insurance unions and companies that are the Company’s clients.
As a result, segment revenue for the three months ended June 30, 2024 was ¥6,606 million and segment
profit (segment EBITDA) was ¥1,301 million.
Tele-medicine
The Group has the biggest platform for radiologists in Japan. In the three months ended June 30, 2024,
revenue increased on a year-on-year basis as a result of the continued increase in the number of medical
institutions utilizing remote image interpretation services.
We continue to take measures to expand our business, including adding functions to “AI-RAD,” anartificial intelligence engine platform that assists in diagnostic imaging, and preparations for full-scalebusiness development in Asia.
As a result, segment revenue for the three months ended June 30, 2024 was ¥1,500 million and segment
profit (segment EBITDA) was ¥532 million.
Dispensing Pharmacy Support
During the three months ended June 30, 2024, we worked to cultivate new customers while securing
replacement demand from existing customers. In the environment surrounding dispensing pharmacies,
the intensity of competition has increased as digitalization has advanced.
Amid the above-mentioned situation, the Company transferred all shares of Unike Software ResearchCo., Ltd., a component of the Company’s Dispensing Pharmacy Support segment, and its management
purpose company to the Company’s business partner EM Systems Co., Ltd. in June 2023. Due to thistransfer, the Company will provide even higher quality services by further acceleration initiatives taken-3-

JMDC Inc. (4483)

thus far by both companies, and make a splash in the pharmacy market, which will increase theCompany’s market share.
As a result, segment revenue for the three months ended June 30, 2024 was ¥326 million and segment
profit (segment EBITDA) was ¥58 million.
As a result of the above, for the three months ended June 30, 2024, revenue was ¥8,422 million,
operating profit was ¥1,089 million, and EBITDA was ¥1,718 million. Adjustments to reconcile
EBITDA to operating profit are as follows.
(Reconciliation of EBITDA to operating profit)

EBITDA
Depreciation and amortization
Other income
Other expenses
Operating profit

11th fiscal year
Three months ended
June 30, 2023
1,679
(551)
1,458
(40)
2,546

(Millions of yen)
12th fiscal year
Three months ended
June 30, 2024
1,718
(664)
47
(10)
1,089

(2) Outline of financial position for the three months ended June 30, 2024
(i) Assets, liabilities and equity
AssetsAssets at the end of the first quarter under review were ¥121,369 million, a decrease of ¥1,083
million compared with the end of the fiscal year ended March 31, 2024. Major changes included anincrease of ¥3,401 million in cash and cash equivalents and a decrease of ¥6,926 million in tradeand other receivables. For details regarding the changes in cash and cash equivalents, please referto “(ii) Cash flows.”
Liabilities
Liabilities at the end of the first quarter under review were ¥50,972 million, a decrease of ¥793
million compared with the end of the fiscal year ended March 31, 2024. This was mainly due todecreases of ¥1,487 million in borrowings in current liabilities due to repayments and ¥773 million
in income taxes payable due to their payment, despite an increase of ¥1,070 million in contract
liabilities in current liabilities.
EquityEquity at the end of the first quarter under review was ¥70,397 million, a decrease of ¥289 million
compared with the end of the fiscal year ended March 31, 2024. This was mainly due to therecording of ¥730 million in profit while dividends of ¥914 million were recorded.
(ii) Cash flows
Cash and cash equivalents (“net cash”) at the end of the first quarter under review was ¥17,875
million, an increase of ¥3,401 million compared with the end of the fiscal year ended March 31,
2024.
The respective cash flow positions for the three months ended June 30, 2024, and the factors
thereof are as follows.
Cash flows from operating activities
During the three months ended June 30, 2024, profit before tax was ¥1,072 million, a decrease of¥1,479 million on a year-on-year basis. While income taxes paid of ¥1,290 million was recorded,
depreciation and amortization of ¥664 million, decrease in trade and other receivables of ¥6,925
million, increase in contract liabilities of ¥1,346 million, and other items were recorded, resulting
in net cash provided by operating activities of ¥7,910 million. Although increase (decrease) in-4-

JMDC Inc. (4483)

contract liabilities had been included in other up to the end of the fiscal year ended March 31, 2024,
after a review due to the increased materiality, they are presented separately from the first quarter
under review. The consolidated financial statements for the three months ended June 30, 2023 havebeen reclassified to reflect this change in presentation.
Cash flows from investing activities
Net cash used in investing activities was ¥1,599 million. This was primarily due to purchase ofinvestments of ¥594 million, purchase of property, plant and equipment of ¥434 million andpurchase of intangible assets of ¥317 million.
Cash flows from financing activities
Net cash used in financing activities was ¥2,911 million. This was primarily due to the recording of¥1,701 million in repayments of short-term borrowings and ¥910 million in dividends paid.
(3) Explanation of consolidated earnings forecasts and other forward-looking statements
The consolidated earnings forecasts for the fiscal year ending March 31, 2025 are unchanged from theforecasts announced on May 7, 2024. However, as shown below, the Company has decided toannounce the consolidated earnings forecasts for the six months ending September 30, 2024. Becauseof how the Group’s business is constructed, its consolidated earnings are concentrated in the second
half of the fiscal year, which makes it difficult to provide a forecast for the first half of the fiscal year.
Accordingly, the Company has a policy not to announce the consolidated earnings forecasts for the firstsix-month period. Nevertheless, because of the smooth progress of the business environment, which
has enhanced our visibility of the first half of the fiscal year, the Company has decided to disclose anearnings forecast for the first six-month period.

Revenue

OperatingprofitProfit before
tax

Millions of yen

Millions of yen

Millions of yen

ProfitProfitattributable toowners ofparentBasicearnings per
share

Millions of yen

Millions of yen

Yen

Previously announced
forecast (A)

–

–

–

–

–

–

Revised forecast (B)18,700

2,800

2,750

1,850

1,850

28.31

Increase (Decrease) (B-A)

–

–

–

–

–

–

Increase (Decrease)percentage (%)

–

–

–

–

–

–

13,746

3,602

3,615

2,663

2,662

42.20

(Reference) Actual results forthe six months ended
September 30, 2023

-5-

JMDC Inc. (4483)

2. Condensed quarterly consolidated financial statements and significant notes thereto(1) Condensed quarterly consolidated statement of financial position
As of March 31, 2024
AssetsCurrent assets
Cash and cash equivalents
Trade and other receivables
Contract assets
Other financial assets
Inventories
Other current assets
Total current assets
Non-current assets
Property, plant and equipment
Goodwill
Intangible assets
Other financial assets
Deferred tax assets
Other non-current assets
Total non-current assets
Total assets
Liabilities and equity
Liabilities
Current liabilities
Borrowings
Trade and other payables
Lease liabilities
Income taxes payable
Contract liabilities
Other current liabilities
Total current liabilities
Non-current liabilities
Borrowings
Lease liabilities
Retirement benefit liability
Provisions
Deferred tax liabilities
Contract liabilities
Other non-current liabilities
Total non-current liabilities
Total liabilities
EquityShare capital
Capital surplus
Treasury shares
Other components of equity
Retained earnings
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Total liabilities and equity-6-(Millions of yen)
As of June 30, 2024

14,47322,152
21
3,619
249
879

17,875
15,226
721
3,889
332
1,046

41,39539,092

12,72455,974
5,768
4,541
1,771
277

13,071
55,974
5,832
5,146
1,954
298

81,057

82,277

122,452

121,369

22,352
5,975
1,086
1,316
1,462
2,041

20,865
6,288
1,111
543
2,533
1,855

34,23533,197

6,574
7,819
205
472
699
1,535
223
17,530

6,447
7,913
207
476
692
1,811
226
17,774

51,76550,97225,09928,304(3)
23
17,16625,101
28,194(3)
21
16,98270,59070,29696

101

70,68670,397

122,452

121,369

JMDC Inc. (4483)(2) Condensed quarterly consolidated statement of profit or loss and condensed quarterly
consolidated statement of comprehensive income
Condensed quarterly consolidated statement of profit or loss
(Millions of yen)Three months ended
June 30, 2023

Three months ended
June 30, 2024

Revenue
Cost of sales

6,698
2,999

8,422
3,720

Gross profit
Selling, general and administrative expenses
Other income
Other expenses

3,698
2,570
1,458
40

4,702
3,648
47
10

Operating profit
Finance income
Finance costs
Share of profit (loss) of investments accounted for using
equity method

2,546
20
14

1,089
17
34

–

(0)

Profit before tax
Income tax expense

2,552
512

1,072
342

Profit2,040

730

Profit attributable to
Owners of parent
Non-controlling interests

2,040
(0)

727
2

2,040

730

32.42
31.07

11.14
11.03

ProfitEarnings per share
Basic earnings per share (Yen)
Diluted earnings per share (Yen)-7-

JMDC Inc. (4483)

Condensed quarterly consolidated statement of comprehensive income(Millions of yen)Three months ended
June 30, 2023
ProfitThree months ended
June 30, 2024

2,040

730

3

3

3

3

(0)

(1)

(0)

(1)

3

1

Comprehensive income

2,043

731

Comprehensive income attributable to
Owners of parent
Non-controlling interests

2,043
(0)

728
2

2,043

731

Other comprehensive income
Items that will not be reclassified to profit or loss
Financial assets measured at fair value through othercomprehensive income
Total of items that will not be reclassified to profit
or loss
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign
operations
Total of items that may be reclassified to profit orloss
Other comprehensive income, net of tax

Comprehensive income-8-

JMDC Inc. (4483)(3) Condensed quarterly consolidated statement of changes in equity
Three months ended June 30, 2023 (from April 1 to June 30, 2023)(Millions of yen)
Equity attributable to owners of parent
Other components of equity

Balance as of April 1, 2023

Share capital

Capital surplus

Treasury shares

Exchangedifferences ontranslation offoreign operations

Financial assets
measured at fairvalue throughothercomprehensive
incomeShare acquisitionrights23,994

27,211

(2)

(4)

–

32

Profit

–

–

–

–

–

–

Other comprehensive
income

–

–

–

(0)

3

–

Total comprehensive income

–

–

–

(0)

3

–

Exercise of shareacquisition rights

14

14

–

–

–

(0)

Purchase of treasury shares

–

–

(0)

–

–

–

Dividends

–

–

–

–

–

–

Transfer to retained
earnings

–

–

–

–

(3)

–

Total transactions withowners

14

14

(0)

–

(3)

(0)

24,00827,225

(2)

(5)

–

31

Balance as of June 30, 2023

Equity attributable to owners of parent
Other componentsof equity
Retained earnings

Non-controllinginterests

Total

Total

Total
Balance as of April 1, 2023

28

13,30864,539(14)

64,524

Profit

–

2,040

2,040

(0)

2,040

Other comprehensive
income

3

–

3

–

3

3

2,040

2,043

(0)

2,043

(0)

–

28

–

28

Total comprehensive income
Exercise of shareacquisition rights
Purchase of treasury shares

–

–

(0)

–

(0)

Dividends

–

(754)

(754)

–

(754)

Transfer to retained
earnings

(3)

3

–

–

–

Total transactions withowners

(4)

(751)

(726)

–

(726)

Balance as of June 30, 2023

26

14,59765,856(14)

65,841-9-JMDC Inc. (4483)

Three months ended June 30, 2024 (from April 1 to June 30, 2024)(Millions of yen)
Equity attributable to owners of parent
Other components of equity

Balance as of April 1, 2024

Share capital

Capital surplus

Treasury shares

Exchangedifferences ontranslation offoreign operations

Financial assets
measured at fairvalue throughothercomprehensive
incomeShare acquisitionrights30

25,09928,304

(3)

(6)

–

Profit

–

–

–

–

–

–

Other comprehensive
income

–

–

–

(1)

3

–

Total comprehensive income

–

–

–

(1)

3

–

Exercise of shareacquisition rights

1

1

–

–

–

(0)

Forfeiture of shareacquisition rights

–

0

–

–

–

(0)

Purchase of treasury shares

–

–

(0)

–

–

–

Dividends

–

–

–

–

–

–

Transactions with noncontrolling interests

–

(112)

–

–

–

–

Transfer to retained
earnings

–

–

–

–

(3)

–

Total transactions withowners

1

(109)

(0)

–

(3)

(0)

25,101

28,194

(3)

(8)

–

29

Balance as of June 30, 2024

Equity attributable to owners of parent
Other componentsof equity
Retained earnings

Non-controllinginterests

Total

Total

Total
Balance as of April 1, 2024

23

17,16670,59096

70,686

Profit

–

727

727

2

730

Other comprehensive
income

1

–

1

–

1

Total comprehensive income

1

727

728

2

731

Exercise of shareacquisition rights

(0)

–

3

–

3

Forfeiture of shareacquisition rights

(0)

–

–

–

–

Purchase of treasury shares

–

–

(0)

–

(0)

Dividends

–

(914)

(914)

–

(914)

Transactions with noncontrolling interests

–

–

(112)

2

(109)

Transfer to retained
earnings

(3)

3

–

–

–

Total transactions withowners(3)(911)(1,023)2(1,021)

Balance as of June 30, 2024

21

16,98270,296

101

70,397- 10 -

JMDC Inc. (4483)(4) Condensed quarterly consolidated statement of cash flows(Millions of yen)Three months ended
June 30, 2023
Cash flows from operating activities
Profit before tax
Depreciation and amortization
Other income
Decrease (increase) in trade and other receivables
Decrease (increase) in contract assets
Decrease (increase) in inventories
Increase (decrease) in trade and other payables
Increase (decrease) in contract liabilities
Other
SubtotalInterest and dividends received
Interest paid
Income taxes paid
Net cash provided by (used in) operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
Purchase of intangible assets
Payments for loans receivable
Purchase of investments
Purchase of shares of subsidiaries resulting in change
in scope of consolidation
Proceeds from sale of shares of subsidiaries resulting
in change in scope of consolidation
Other
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from short-term borrowings
Repayments of short-term borrowings
Proceeds from long-term borrowings
Repayments of long-term borrowings
Repayments of lease liabilities
Proceeds from exercise of share acquisition rights
Dividends paid
Other

Three months ended
June 30, 2024

2,552
551
(1,458)
1,523
(13)
6
(701)
436
(259)

1,072
664
(47)
6,925
(700)
(83)
333
1,346
(277)

2,636
0
(5)
(1,191)

9,235
0
(33)
(1,290)

1,439

7,910

(62)
(263)
–
(0)

(434)
(317)
(210)
(594)

(1,450)

–

273

–

37

(43)

(1,465)(1,599)

1,701
–
28
(529)
(223)
48
(751)
(0)

300
(1,701)
–
(213)
(279)
3
(910)
(110)

Net cash provided by (used in) financing activities273(2,911)

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Effect of exchange rate changes on cash and cash
equivalents

247
22,7823,400
14,473(0)0Cash and cash equivalents at end of period

23,02917,875- 11 -

JMDC Inc. (4483)(5) Notes to condensed quarterly consolidated financial statements
Notes on going concern assumption
Not applicable.
Segment information(1) Overview of reportable segments
The Group’s reportable segments are components of the Group for which discrete financial information
is available, and whose operating results are regularly reviewed by the Board of Directors to makedecisions about managerial resources to be allocated to the segments and assess their performances.
The Group considers similarities in the nature of the services it provides and has three reportablesegments: “Healthcare-Big Data,” “Tele-medicine,” and “Dispensing Pharmacy Support.”
The main businesses and main services included in each reportable segment are as follows.
Reportable segments

Main businesses

Main services

Healthcare-Big Data

Business for industry
Business for payers and individuals
Business for medical service providers

Development and provision of medical
databases (receipts, pharmaceuticals,etc.) and analysis of medical big data

Tele-medicine

Tele-medicine business

Remote image interpretation matching
service and ASP service for remote
image interpretation system

Dispensing Pharmacy
SupportDispensing pharmacy support business

Development and sales of businesssystems for dispensing pharmacies(2) Information about reportable segments
Revenue and operating results by reportable segments of the Group are as follows.
Intersegment revenues are based on negotiated transaction prices, taking into account market prices andproduction costs. Segment profits are EBITDA (Operating profit + Depreciation and amortization ±Other income and/or expenses).
Three months ended June 30, 2023 (from April 1 to June 30, 2023)(Millions of yen)
Reportable segments
HealthcareBig Data
Revenue
Revenue fromexternalcustomers
Intersegment
revenue
Total
Segment profit
EBITDA

Tele-medicine

Dispensing
Pharmacy
Support

Total

Adjustments(Note)

Consolidated

4,472

1,307

919

6,698

–

6,698

25

–

50

76

(76)

–

4,497

1,307

969

6,774

(76)

6,698

1,294

448

87

1,831

(151)

1,679

Note: Adjustments include elimination of intersegment transactions and corporate expenses.

- 12 -

JMDC Inc. (4483)

Three months ended June 30, 2024 (from April 1 to June 30, 2024)(Millions of yen)
Reportable segments
HealthcareBig Data
Revenue
Revenue fromexternalcustomers
Intersegment
revenue
Total
Segment profit
EBITDA

Tele-medicine

Dispensing
Pharmacy
Support

Total

Adjustments(Note)

Consolidated

6,595

1,500

326

8,422

–

8,422

10

–

–

10

(10)

–

6,606

1,500

326

8,433

(10)

8,422

1,301

532

58

1,893

(174)

1,718

Note: Adjustments include elimination of intersegment transactions and corporate expenses.

A reconciliation of EBITDA to profit before tax is as follows.

EBITDA
Depreciation and amortization
Other income
Other expenses
Operating profit
Finance income
Finance costs
Share of profit (loss) of investments
accounted for using equity method
Profit before tax

Three months ended
June 30, 2023
1,679
(551)
1,458
(40)
2,546
20
(14)

Significant subsequent events
Not applicable.

- 13 -(Millions of yen)Three months ended
June 30, 2024
1,718
(664)
47
(10)
1,089
17
(34)

–

0

2,552

1,072